查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1667816

2025 年免疫血液學全球市場報告

Immunohematology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年免疫血液學市場規模將強勁成長。到 2029 年，這一數字將成長到 32.4 億美元，年複合成長率（CAGR）為 5.9%。預測期內的成長可歸因於就地檢驗的需求不斷增加、新型血液製品的出現、醫療保健基礎設施的擴大、血液相容性的基因檢測以及對血液安全的監管支持。預測期內的主要趨勢包括自動化和高通量系統、分子血型、抗體檢測技術、患者血液管理計劃、分析中的人工智慧整合以及遠端醫療整合。

預計血液疾病盛行率的上升將在短期內推動免疫血液學市場的成長。影響紅血球、白血球、血小板和血漿等血液成分的血液疾病需要使用免疫血液學進行安全有效的輸血。這有助於防止因血型不相容或受血者血液中存在抗體而引起的輸血反應。免疫血液學技術在影響免疫系統的疾病的診斷和治療中也發揮著重要作用，也可能對血液系統產生影響。例如，英國癌症研究中心報告稱，血液疾病預計將導致英國白血病新病例增加，從 2023-2025 年的約 12,400 例增加到 2038-2040 年的約 14,500 例。因此，血液疾病盛行率的上升是支持免疫血液學市場成長的關鍵因素。

預計免疫血液學市場的成長將受到人口老化加劇的推動。老化是指社會中老年人口比例不斷增加的一種人口趨勢。免疫血液學在滿足該族群的輸血需求、確保血液製品的安全使用以及促進老年人的醫療干預方面發揮關鍵作用。例如，2024年1月，美國非營利組織人口研究所預測，到2050年，美國數將增加47％，從2022年的5,800萬人增加至8,200萬人。而且，這一年齡層人口佔總人口的比例預計在同一時期將從17％增加到23％。因此，人口老化是推動免疫血液學市場擴張的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 世界免疫血液學PESTEL分析（政治、社會、科技、環境、法律因素、促進因素、抑制因素）
  • 最終用途產業分析
  • 全球免疫血液學市場：成長率分析
  • 全球免疫血液學市場表現：規模與成長，2019 年至 2024 年
  • 全球免疫血液學市場預測：規模與成長，2024-2029 年，2034 年預測
  • 全球免疫血液學總目標市場 (TAM)

第6章 市場細分

  • 全球免疫血液學市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分析儀器和系統
  • 試劑
  • 全球免疫血液學市場（按技術、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 生物晶片
  • 紅血球磁化技術（Met）
  • 啫咖哩卡
  • 微孔盤
  • 聚合酵素鏈鎖反應（PCR）
  • 全球免疫血液學市場：按疾病、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 血液相關疾病
  • HIV
  • 肝炎
  • 全球免疫血液學市場：按應用、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 輸血前檢測
  • 免疫溶血的調查
  • 周產期檢查
  • 血型分類
  • 白血球和血小板血清學
  • 全球免疫血液學市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 血庫
  • 診斷與參考實驗室
  • 醫院
  • 學術研究所
  • 全球免疫血液學市場，按分析儀和系統類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血型分析儀
  • 交叉配血分析儀
  • 凝膠卡系統
  • 全球免疫血液學市場，按試劑類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血型鑑定試劑
  • 抗血清
  • 品控血清

第7章 區域和國家分析

  • 全球免疫血液學市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球免疫血液學市場：按國家、表現和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

  • 免疫血液學市場：競爭格局
  • 免疫血液學市場：公司簡介
    • Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Grifols SA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Company
  • Merck Co. & KGaA
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Danaher Corporation
  • Biosystems SA
  • Roche Holdings AG
  • Mindray Medical International Limited
  • F.Hoffmann La-Roche Ltd.
  • Biotest AG
  • Cardinal Health Inc.
  • Quotient Limited
  • DiaSorin SpA

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年免疫血液學市場：提供新機會的國家
  • 2029 年免疫血液學市場：細分市場將帶來新機會
  • 2029 年免疫血液學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 36 章 附錄

簡介目錄
Product Code: r24221

Immunohematology is a subfield of laboratory medicine that focuses on the study of blood groups and the immune response of the body to foreign substances, particularly in the context of blood transfusions. Immunohematological techniques are employed to identify and address diagnostic issues in patients with hematological conditions, including auto-immune hemolytic anemia.

The main components of immunohematology include analyzers and systems, along with reagents. Analyzers and systems are automated instruments designed for blood typing and antibody screening. Various technologies are utilized in this field, such as biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR). These technologies are applied in the treatment of various diseases such as HIV and hepatitis. The diverse applications encompass pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, leucocyte and platelet serology. The end-users of immunohematology products include blood banks, diagnostic and reference laboratories, hospitals, as well as academic and research institutes.

The immunohematology market research report is one of a series of new reports from The Business Research Company that provides immunohematology optical components market statistics, including immunohematology optical components industry global market size, regional shares, competitors with a immunohematology optical components market share, detailed immunohematology optical components market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology optical components industry. This immunohematology optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market size has grown steadily in recent years. It will grow from$2.46 billion in 2024 to $2.57 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to advancements in blood transfusion science, the prevalence of blood disorders, the expansion of blood banks, government initiatives for blood safety, increased surgical procedures, and awareness of transfusion-related risks

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety. Major trends in the forecast period include automation and high-throughput systems, molecular blood typing methods, antibody detection techniques, patient blood management programs, integration of ai in analysis, telemedicine integration.

The anticipated rise in the prevalence of hematological disorders is set to drive the growth of the immunohematology market in the foreseeable future. Hematological disorders, affecting blood components such as red blood cells, white blood cells, platelets, and plasma, necessitate the use of immunohematology for safe and effective blood transfusions. This helps prevent transfusion reactions arising from incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques also play a crucial role in diagnosing and treating diseases impacting the immune system, with potential implications for the hematological system. For instance, Cancer Research UK reported an expected increase in new leukemia cases due to hematological disorders in the UK, rising from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the escalating prevalence of hematological disorders is a key driver behind the growth of the immunohematology market.

The growth of the immunohematology market is anticipated to be driven by the increasing aging population. An aging population refers to a demographic trend marked by a higher proportion of elderly individuals within a society. Immunohematology plays a crucial role in meeting the transfusion needs of this demographic, ensuring the safe use of blood products, and facilitating medical interventions for older adults. For instance, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, this age group's share of the total population is expected to grow from 17% to 23% during the same period. Therefore, the aging population is a significant factor driving the expansion of the immunohematology market.

Leading companies in the immunohematology market are focused on creating innovative diagnostic solutions, such as soluble recombinant proteins that can mitigate the interference caused by the cancer therapy daratumumab. Soluble recombinant proteins are produced using recombinant DNA technology, maintaining their proper structure and functionality in a soluble form within a host cell or solution, making them suitable for research and therapeutic applications. For example, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, introduced the Grifols sCD38 solution. This product is the first-ever soluble recombinant protein developed specifically to address the interference that daratumumab causes in essential blood transfusion compatibility testing. Targeted at patients with multiple myeloma, this groundbreaking solution prevents daratumumab from binding to CD38 proteins on red blood cells, ensuring accurate pre-transfusion test results. By streamlining the processes of screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and reduces delays in administering lifesaving transfusions.

Major companies operating in the immunohematology market are innovating by introducing new products such as self-sampling blood collection products to enhance their market profitability. Self-sampling blood collection involves individuals collecting their own blood samples for diagnostic purposes without the need for healthcare professionals. For example, in February 2023, Capitainer launched CapitainerB 50, a self-sampling blood collection device that protects samples from contamination. The microsampling technology employed ensures precise quantitative sampling comparable to conventional pipetting.

In March 2023, Werfen, S.A., a diagnostic care company based in Spain, completed the acquisition of Immucor Inc. for approximately $2 billion. This strategic move aimed to expand Werfen's capabilities in specialized diagnostic testing, particularly within diagnostic solutions. Immucor Inc., a transfusion diagnostics company based in Spain, focuses on providing safe, accessible, and affordable blood tests.

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohematology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohematology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohematology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunohematology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Analyzers And Systems; Reagents
  • 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (Met); Gel Cards; Microplates; Polymerase Chain Reaction (PCR)
  • 3) By Disease: Blood-Related Diseases; HIV; Hepatitis
  • 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
  • 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
  • Subsegments:
  • 1) By Analyzers And Systems: Blood Typing Analyzers; Cross-Matching Analyzers; Gel Card Systems
  • 2) By Reagents: Blood Grouping Reagents; Antisera; Control Serum
  • Companies Mentioned: Ortho Clinical Diagnostics Inc.; Immunocor Inc.; Abbott Laboratories; Siemens Healthineers AG; Grifols S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunohematology Market Characteristics

3. Immunohematology Market Trends And Strategies

4. Immunohematology Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Immunohematology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunohematology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunohematology Market Growth Rate Analysis
  • 5.4. Global Immunohematology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunohematology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunohematology Total Addressable Market (TAM)

6. Immunohematology Market Segmentation

  • 6.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analyzers And Systems
  • Reagents
  • 6.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biochips
  • Erythrocyte-Magnetized Technology (Met)
  • Gel Cards
  • Microplates
  • Polymerase Chain Reaction (PCR)
  • 6.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood-Related Diseases
  • HIV
  • Hepatitis
  • 6.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pretransfusion Testing
  • Investigation Of Immune Hemolysis
  • Perinatal Testing
  • Blood Group Phenotyping
  • Leucocyte And Platelet Serology
  • 6.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Banks
  • Diagnostic And Reference Laboratories
  • Hospitals
  • Academic And Research Institutes
  • 6.6. Global Immunohematology Market, Sub-Segmentation Of Analyzers And Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing Analyzers
  • Cross-Matching Analyzers
  • Gel Card Systems
  • 6.7. Global Immunohematology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Grouping Reagents
  • Antisera
  • Control Serum

7. Immunohematology Market Regional And Country Analysis

  • 7.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunohematology Market

  • 8.1. Asia-Pacific Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunohematology Market

  • 9.1. China Immunohematology Market Overview
  • 9.2. China Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunohematology Market

  • 10.1. India Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunohematology Market

  • 11.1. Japan Immunohematology Market Overview
  • 11.2. Japan Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunohematology Market

  • 12.1. Australia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunohematology Market

  • 13.1. Indonesia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunohematology Market

  • 14.1. South Korea Immunohematology Market Overview
  • 14.2. South Korea Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunohematology Market

  • 15.1. Western Europe Immunohematology Market Overview
  • 15.2. Western Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunohematology Market

  • 16.1. UK Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunohematology Market

  • 17.1. Germany Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunohematology Market

  • 18.1. France Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunohematology Market

  • 19.1. Italy Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunohematology Market

  • 20.1. Spain Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunohematology Market

  • 21.1. Eastern Europe Immunohematology Market Overview
  • 21.2. Eastern Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunohematology Market

  • 22.1. Russia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunohematology Market

  • 23.1. North America Immunohematology Market Overview
  • 23.2. North America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunohematology Market

  • 24.1. USA Immunohematology Market Overview
  • 24.2. USA Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunohematology Market

  • 25.1. Canada Immunohematology Market Overview
  • 25.2. Canada Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunohematology Market

  • 26.1. South America Immunohematology Market Overview
  • 26.2. South America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunohematology Market

  • 27.1. Brazil Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunohematology Market

  • 28.1. Middle East Immunohematology Market Overview
  • 28.2. Middle East Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunohematology Market

  • 29.1. Africa Immunohematology Market Overview
  • 29.2. Africa Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunohematology Market Competitive Landscape And Company Profiles

  • 30.1. Immunohematology Market Competitive Landscape
  • 30.2. Immunohematology Market Company Profiles
    • 30.2.1. Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Immunohematology Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter Inc.
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Becton Dickinson and Company
  • 31.4. Merck Co. & KGaA
  • 31.5. Bio-Rad Laboratories
  • 31.6. Sysmex Corporation
  • 31.7. Danaher Corporation
  • 31.8. Biosystems S.A.
  • 31.9. Roche Holdings AG
  • 31.10. Mindray Medical International Limited
  • 31.11. F.Hoffmann La-Roche Ltd.
  • 31.12. Biotest AG
  • 31.13. Cardinal Health Inc.
  • 31.14. Quotient Limited
  • 31.15. DiaSorin S.p.A.

32. Global Immunohematology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunohematology Market

34. Recent Developments In The Immunohematology Market

35. Immunohematology Market High Potential Countries, Segments and Strategies

  • 35.1 Immunohematology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunohematology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunohematology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer